Abstract
Clinically significant fetomaternal hemorrhage (FMH) can have devastating consequences on the newborn infant. Acute FMH close to childbirth can present with hypovolemia, shock, metabolic acidosis, and encephalopathy. Chronic FMH can be associated with congestive heart failure, pulmonary edema, hydrops and hepatomegaly. Early recognition and timely management of FMH are crucial in improving outcomes. This review article summarizes the epidemiology, pathogenesis, diagnosis, management and outcomes of clinically significant FMH. Current knowledge gaps in diagnosis and management of FMH are additionally described.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
39,95 €
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others
References
Bianchi DW. Fetomaternal cell trafficking: a story that begins with prenatal diagnosis and may end with stem cell therapy. J Pediatr Surg. 2007;42:12–18.
Wylie BJ, D’Alton ME. Fetomaternal hemorrhage. Obstet Gynecol. 2010;115:1039–51.
Kadooka M, Kato H, Kato A, Ibara S, Minakami H, Maruyama Y. Effect of neonatal hemoglobin concentration on long-term outcome of infants affected by fetomaternal hemorrhage. Early Hum Dev. 2014;90:431–4.
Maier JT, Schalinski E, Schneider W, Gottschalk U, Hellmeyer L. Fetomaternal hemorrhage (FMH), an update: review of literature and an illustrative case. Arch Gynecol Obstet. 2015;292:595–602.
Sebring E, Polesky H. Fetomaternal hemorrhage: incidence, risk factors, time of occurrence, and clinical effects. Transfusion. 1990;30:344–57.
Sebring ES, Polesky HF. Fetomaternal hemorrhage: incidence, risk factors, time of occurrence, and clinical effects. Transfusion. 1990;30:344–57. https://doi.org/10.1046/j.1537-2995.1990.30490273444.x.
Rubod C, Deruelle P, Le Goueff F, Tunez V, Fournier M, Subtil D. Long-term prognosis for infants after massive fetomaternal hemorrhage. Obstet Gynecol. 2007;110:256–60. https://doi.org/10.1097/01.Aog.0000271212.66040.70.
de ALMEIDA V, BOWMAN JM. Massive fetomaternal hemorrhage: manitoba experience. Obstet Gynecol. 1994;83:323–8.
Christensen RD, Lambert DK, Baer VL, Richards DS, Bennett ST, Ilstrup SJ, et al. Severe neonatal anemia from fetomaternal hemorrhage: report from a multihospital health-care system. J Perinatol. 2013;33:429–34. https://doi.org/10.1038/jp.2012.142.
Carr NR, Henry E, Bahr TM, Ohls RK, Page JM, Ilstrup SJ, et al. Fetomaternal hemorrhage: evidence from a multihospital healthcare system that up to 40% of severe cases are missed. Transfusion. 2022;62:60–70. https://doi.org/10.1111/trf.16710.
Halling C, Raymond T, Brown LS, Ades A, Foglia EE, Allen E, et al. Neonatal delivery room CPR: an analysis of the Get with the Guidelines®-Resuscitation Registry. Resuscitation. 2021;158:236–42. https://doi.org/10.1016/j.resuscitation.2020.10.007.
Dunn PM. Tight nuchal cord and neonatal hypovolaemic shock. Arch Dis Child. 1988;63:570–1. https://doi.org/10.1136/adc.63.5.570-a.
Boucher M, Marquette GP, Varin J, Champagne J, Bujold E. Fetomaternal hemorrhage during external cephalic version. Obstet Gynecol. 2008;112:79–84. https://doi.org/10.1097/AOG.0b013e318179978c.
Goodwin TM, Breen MT. Pregnancy outcome and fetomaternal hemorrhage after noncatastrophic trauma. Am J Obstet Gynecol. 1990;162:665–71. https://doi.org/10.1016/0002-9378(90)90979-H.
Henningsen A-KA, Maroun LL, Havsteen H, Svare J. Massssive fetomaternal hemorrhage caused by an intraplacental choriocarcinoma: a case reF. Case Rep Med. 2010;2010:767218. https://doi.org/10.1155/2010/767218.
Samura O, Miharu N, Hyodo M, Honda H, Ohashi Y, Honda N, et al. Cell-free fetal DNA in maternal circulation after amniocentesis. Clin Chem. 2003;49:1193–5. https://doi.org/10.1373/49.7.1193.
Sikovanyecz J, Horváth E, Pásztor N, Keresztúri A, Szabó J, Pál A. Fetomaternal transfusion after amniocentesis and cordocentesis. Ir J Med Sci. 2011;180:697–701. https://doi.org/10.1007/s11845-010-0663-3.
Brandt JS, Ananth CV. Placental abruption at near-term and term gestations: pathophysiology, epidemiology, diagnosis, and management. Am J Obstet Gynecol. 2023;228:S1313–S1329. https://doi.org/10.1016/j.ajog.2022.06.059.
Faiz AS, Ananth CV. Etiology and risk factors for placenta previa: an overview and meta-analysis of observational studies. J Matern Fetal Neonatal Med. 2003;13:175–90. https://doi.org/10.1080/jmf.13.3.175.190.
Rincon M, Rhodes H, Boniface E, Pereira L, D’Mello RJ, Hayer S, et al. The natural history and management of vasa previa: a single institution’s 15-year experience managing patients remote from labor and delivery. BMC Pregnancy Childbirth. 2025;25:581. https://doi.org/10.1186/s12884-025-07708-8.
Mendez-Figueroa H, Dahlke JD, Vrees RA, Rouse DJ. Trauma in pregnancy: an updated systematic review. Am J Obstet Gynecol. 2013;209:1–10. https://doi.org/10.1016/j.ajog.2013.01.021.
Duzyj CM, Einerson BD, Afshar Y, Fox KA, Saad AF, Carusi DA, et al. Placenta accreta spectrum, present and future: the Eunice Kennedy Shriver National Institute of Child Health and Human Development Workshop Summary. Obstet Gynecol. 2025;145:581–5. https://doi.org/10.1097/aog.0000000000005929.
Kawakita T, Huang CC, Landy HJ. Risk factors for umbilical cord prolapse at the time of artificial rupture of membranes. AJP Rep. 2018;8:e89–e94. https://doi.org/10.1055/s-0038-1649486.
Chen R, Lin L. Spontaneous umbilical cord vascular rupture during labor: a retrospective analysis of 12 cases. Am J Perinatol. 2025;42:586–92. https://doi.org/10.1055/a-2412-3169.
Silva GV, Gontijo CT, Lunguinho APC, Caetano MSG, Callado GY, Araujo Júnior E et al. Perinatal outcomes related to the presence of a nuchal cord during delivery: a retrospective cohort study. Diagnostics (Basel). 2025;15. https://doi.org/10.3390/diagnostics15101197.
Boller M, Navarrete E, Hung Y-Y, Weintraub MR, Moore GS, Schauer GM. Placental abruption is not associated with clinically significant fetomaternal hemorrhage [29O]. Obstetr Gynecol. 2020;135. https://doi.org/10.1097/01.AOG.0000664028.44953.c0.
Devi B, Jennison RF, Langley FA. Significance of placental pathology in transplacental haemorrhage. J Clin Pathol. 1968;21:322–31. https://doi.org/10.1136/jcp.21.3.322.
Vrancken SL, van Heijst AF, de Boode WP. Neonatal hemodynamics: from developmental physiology to comprehensive monitoring. Front Pediatr. 2018;6:87. https://doi.org/10.3389/fped.2018.00087.
Sankaran D, Lane ECA, Valdez R, Lesneski AL, Lakshminrusimha S. Role of volume replacement during neonatal resuscitation in the delivery room. Children (Basel). 2022;9. https://doi.org/10.3390/children9101484.
Henry E, Andres RL, Christensen RD. Neonatal outcomes following a tight nuchal cord. J Perinatol. 2013;33:231–4. https://doi.org/10.1038/jp.2012.79.
Peesay M. Nuchal cord and its implications. Matern Health Neonatol Perinatol. 2017;3:28. https://doi.org/10.1186/s40748-017-0068-7.
Yao A, Moinian M, Lind J. Distribution of blood between infant and placenta after birth. Lancet. 1969;294:871–3.
Naulaers G, Barten S, Vanhole C, Verhaeghe J, Devlieger H. Management of severe neonatal anemia due to fetomaternal transfusion. Am J Perinatol. 1999;16:193–6. https://doi.org/10.1055/s-2007-993857.
Polglase GR, Ong T, Hillman NH. Cardiovascular alterations and multiorgan dysfunction after birth asphyxia. Clin Perinatol. 2016;43:469–83. https://doi.org/10.1016/j.clp.2016.04.006.
ACOG Practice Bulletin No. 106. Intrapartum fetal heart rate monitoring: nomenclature, interpretation, and general management principles. Obstet Gynecol. 2009;114:192–202. https://doi.org/10.1097/AOG.0b013e3181aef106.
Tao E, Ye D, Long G, Hu Y, Fu Q, Yuan T, et al. Severe neonatal anemia affected by massive fetomaternal hemorrhage: a single-center retrospective observational study. J Matern-Fetal Neonatal Med. 2022;35:3972–8. https://doi.org/10.1080/14767058.2020.1845313.
Sá I, Moura M. Sinusoidal pattern: a key to a rare case of fetal anaemia. BMJ Case Rep. 2021;14:e241312 https://doi.org/10.1136/bcr-2020-241312.
Mayer C, Rijhsinghani A, Parikh R. The limitations of middle cerebral artery peak systolic velocity and the need for certification [38A]. Obstetr Gynecol. 2020;135. https://doi.org/10.1097/01.AOG.0000663084.35334.7e.
Sueters M, Arabin B, Oepkes D. Doppler sonography for predicting fetal anemia caused by massive fetomaternal hemorrhage. Ultrasound Obstet Gynecol. 2003;22:186–9. https://doi.org/10.1002/uog.190.
Weiner GM, Zaichkin J, American Academy of Pediatrics, A. H. A. Textbook of Neonatal Resuscitation, 8th Edition. (2021).
Savithrisowmya S, Singh M, Kriplani A, Agarwal N, Mehra NK, Bhatla N. Assessment of fetomaternal hemorrhage by flow cytometry and Kleihauer-Betke test in Rh-negative pregnancies. Gynecol Obstet Invest. 2008;65:84–88. https://doi.org/10.1159/000108401.
Kim YA, Makar RS. Detection of fetomaternal hemorrhage. Am J Hematol. 2012;87:417–23. https://doi.org/10.1002/ajh.22255.
Mercer JS, Erickson-Owens DA, Rabe H. Placental transfusion: may the “force” be with the baby. J Perinatol. 2021;41:1495–504. https://doi.org/10.1038/s41372-021-01055-0.
Aziz K, Lee HC, Escobedo MB, Hoover AV, Kamath-Rayne BD, Kapadia VS, et al. Part 5: Neonatal Resuscitation: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142:S524–S550. https://doi.org/10.1161/CIR.0000000000000902.
Shalish W, Olivier F, Aly H, Sant’Anna G. In Seminars in Fetal and Neonatal Medicine. 328–35 (Elsevier).
Todd SR, Malinoski D, Muller PJ, Schreiber MA. Lactated Ringer’s is superior to normal saline in the resuscitation of uncontrolled hemorrhagic shock. J Trauma. 2007;62:636–9.
Healey MA, Davis RE, Liu FC, Loomis WH, Hoyt DB. Lactated Ringer’s is superior to normal saline in a model of massive hemorrhage and resuscitation. J Trauma Acute Care Surg. 1998;45:894–9.
McIntyre L, Fergusson D, McArdle T, English S, Cook DJ, Fox-Robichaud AE, et al. A Crossover Trial of Hospital-Wide Lactated Ringer’s Solution versus Normal Saline. N Engl J Med. 2025;393:660–70.
ACOG Practice Bulletin No. 192. Management of alloimmunization during pregnancy. Obstet Gynecol. 2018;131:e82–e90. https://doi.org/10.1097/aog.0000000000002528.
Stephenson T, Zuccollo J, Mohajer M. Diagnosis and management of non-immune hydrops in the newborn. Arch Dis Child Fetal Neonatal Ed. 1994;70:F151–154. https://doi.org/10.1136/fn.70.2.f151.
Katheria AC, Rich WD, Lakshminrusimha S. Circulatory emergencies in the delivery room. Semin Fetal Neonatal Med. 2019;24:101030. https://doi.org/10.1016/j.siny.2019.101030.
Rubod C, Deruelle P, Le Goueff F, Tunez V, Fournier M, Subtil D. Long-term prognosis for infants after massive fetomaternal hemorrhage. Obstetr Gynecol. 2007;110:256–60.
Acknowledgements
We would like to thank the funding sources listed below.
Funding
The authors have no conflict of interest to declare. This work has been supported by Research Grant from the American Academy of Pediatrics- Neonatal Resuscitation program (AAP-NRP) (DS, and EG), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and National Institutes of Health HD109443 (DS) and HD072929 (SL), Children’s Miracle Network (DS), and ZOLL Foundation Inc. (DS and EG). The project described was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through grant number UL1 TR001860 and linked award 5KL2TR001859 (DS), 1K08HL181183-01 (DS), and 5KL2TR001859 (ML). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or AAP-NRP. The funder/ sponsor did not participate in planning or devising this work. The authors have no conflict of interest to declare. This work has been supported by Research Grant from the American Academy of Pediatrics- Neonatal Resuscitation program (AAP-NRP) (DS, and EG), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and National Institutes of Health HD109443 (DS) and HD072929 (SL), National Heart, Lung and Blood Institute (NHLBI) 1K08HL181183-01 (DS), Children’s Miracle Network (DS), and ZOLL Foundation Inc. (DS and EG). The project described was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through grant number UL1 TR001860 and linked award 5KL2TR001859 (DS) and 5KL2TR001859 (ML). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or AAP-NRP. The funder/ sponsor did not participate in planning or devising this work.
Author information
Authors and Affiliations
Contributions
DS conceptualized, designed, drafted the initial manuscript, reviewed and revised the manuscript. EG, ML, and SL contributed to the concept, reviewed and revised the manuscript. All the authors have critically revised and approved the final version of the manuscript. All authors agree to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sankaran, D., Giusto, E., Lim, M.J. et al. Fetomaternal hemorrhage: pathogenesis, diagnosis, and clinical management. J Perinatol 46, 1599–1607 (2026). https://doi.org/10.1038/s41372-025-02548-y
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41372-025-02548-y


